Skip to main content
logo
Smith & Nephew plc (SNN)
NYSE: SNN · Real-Time Price · USD
32.96
-0.08 (-0.24%)
At close: Mar 13, 2026, 4:00 PM EDT
32.94
-0.02 (-0.06%)
After-hours: Mar 13, 2026, 7:00 PM EDT

Revenue by Geography

Millions USD. Fiscal year is Jan - Dec.
Fiscal Year
FY 2025FY 2024FY 2023FY 2022FY 2021FY 2020FY 2019FY 2018FY 2017FY 2016FY 2015FY 2014FY 2013FY 2012
Period Ending
Dec '25 Dec '24 Dec '23 Dec '22 Dec '21 Dec '20 Dec '19 Dec '18 Dec '17 Dec '16 Dec '15 Dec '14 Dec '13 Dec '12
US Revenue
3.31B3.12B
US Revenue Growth
5.86%4.83%
Other Established Markets Revenue
1.86B1.71B
Other Established Markets Revenue Growth
8.67%5.96%
Total Established Markets Revenue
5.16B4.83B
Total Established Markets Revenue Growth
6.85%5.23%
Emerging Markets Revenue
1.00B980.00M
Emerging Markets Revenue Growth
2.35%2.19%
Revenue (Total)
-5.81B
Revenue (Total) Growth
-4.70%

Revenue

Millions USD. Fiscal year is Jan - Dec.
Fiscal Year
FY 2025FY 2024FY 2023FY 2022FY 2021FY 2020FY 2019FY 2018FY 2017FY 2016FY 2015FY 2014FY 2013FY 2012
Period Ending
Dec '25 Dec '24 Dec '23 Dec '22 Dec '21 Dec '20 Dec '19 Dec '18 Dec '17 Dec '16 Dec '15 Dec '14 Dec '13 Dec '12
Knee Implants Revenue
1.01B977.00M
Knee Implants Revenue Growth
3.48%3.94%
Hip Implants Revenue
641.00M619.00M
Hip Implants Revenue Growth
3.55%3.34%
Other Reconstruction Revenue
136.00M101.00M
Other Reconstruction Revenue Growth
34.65%-9.01%
Trauma & Extremities Revenue
649.00M608.00M
Trauma & Extremities Revenue Growth
6.74%7.80%
Total Orthopaedics Revenue
2.44B2.31B
Total Orthopaedics Revenue Growth
5.73%4.11%
Sports Medicine Joint Repair Revenue
1.07B982.00M
Sports Medicine Joint Repair Revenue Growth
8.66%3.91%
Arthroscopic Enabling Technologies Revenue
647.00M632.00M
Arthroscopic Enabling Technologies Revenue Growth
2.37%7.48%
ENT (Ear, Nose and Throat) Revenue
220.00M210.00M
ENT (Ear, Nose and Throat) Revenue Growth
4.76%7.14%
Total Sports Medicine & ENT Revenue
1.93B1.82B
Total Sports Medicine & ENT Revenue Growth
6.03%5.50%
Advanced Wound Care Revenue
766.00M735.00M
Advanced Wound Care Revenue Growth
4.22%1.38%
Advanced Wound Bioactives Revenue
621.00M581.00M
Advanced Wound Bioactives Revenue Growth
6.88%5.06%
Advanced Wound Devices Revenue
406.00M365.00M
Advanced Wound Devices Revenue Growth
11.23%11.28%
Total Advanced Wound Management Revenue
1.79B1.68B
Total Advanced Wound Management Revenue Growth
6.66%4.67%
Revenue (Total)
-5.81B
Revenue (Total) Growth
-4.70%

Adjusted EBIT

Millions USD. Fiscal year is Jan - Dec.
Fiscal Year
FY 2025FY 2024FY 2023FY 2022FY 2021FY 2020FY 2019FY 2018FY 2017FY 2016FY 2015FY 2014FY 2013FY 2012
Period Ending
Dec '25 Dec '24 Dec '23 Dec '22 Dec '21 Dec '20 Dec '19 Dec '18 Dec '17 Dec '16 Dec '15 Dec '14 Dec '13 Dec '12
Orthopaedics Segment Profit
363.00M265.00M
Orthopaedics Segment Profit Growth
36.98%5.58%
Sports Medicine & ENT Segment Profit
461.00M437.00M
Sports Medicine & ENT Segment Profit Growth
5.49%10.91%
Advanced Wound Management Segment Profit
447.00M399.00M
Advanced Wound Management Segment Profit Growth
12.03%7.26%
Operating Income (Other)
--444.00M
Operating Income (Total)
-657.00M
Operating Income (Total) Growth
-54.59%
Updated Mar 2, 2026. Data Source: Fiscal.ai.